Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trial
Authors:
- Thomas M. FileTFThomas M. File
- Keith S. KayeKKKeith S. Kaye
- Skliarov IhorSISkliarov Ihor
- Iryna HovbakhIHIryna Hovbakh
- Vakhtang KatsaravaVKVakhtang Katsarava
- Courtney KirschCKCourtney Kirsch
- Karan SoniKSKaran Soni
- Kushagra GuptaKGKushagra Gupta
- Amy ManleyAMAmy Manley
- Daniel H. DeckDDDaniel H. Deck
- Diane AnastasiouDADiane Anastasiou
- Surya ChitraSCSurya Chitra
Open Access
- 21 November 2025
- journal article
- Published by Elsevier in eClinicalMedicine
- Vol. 90
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Health and Human Services
- Biomedical Advanced Research and Development Authority (75A50120C00001)
This publication has 17 references indexed in Scilit:
- Community-Acquired PneumoniaNew England Journal of Medicine, 2023
- ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumoniaIntensive Care Medicine, 2023
- Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019Journal of Global Antimicrobial Resistance, 2021
- Decision Analysis: Omadacycline Relative to Moxifloxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difficile InfectionClinical Drug Investigation, 2021
- Antibiotic Treatment Failure and Associated Outcomes Among Adult Patients With Community-Acquired Pneumonia in the Outpatient Setting: A Real-world US Insurance Claims Database StudyOpen Forum Infectious Diseases, 2020
- Microbiology and Preclinical Review of Omadacycline.Clinical Infectious Diseases, 2019
- Omadacycline for Community-Acquired Bacterial PneumoniaNew England Journal of Medicine, 2019
- Community-Acquired PneumoniaEmergency Medicine Clinics of North America, 2018
- Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of PneumococcusClinical Infectious Diseases, 2017
- Community-acquired pneumoniaThe Lancet, 2015